EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity

Marco Fiorillo iD, Elena Ricci, Mariarosa Fava, Camilla Longobucco, Federica Sotgia, Pietro Rizza, Marilena Lanzino, Daniela Bonofiglio iD, Francesca Luisa Conforti iD, Stefania Catalano, Ines Barone iD, Catia Morelli iD und 3 weitere

Cells · 2023

DOI: 10.3390/cells12242777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Marco Fiorillo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Tamoxifen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Ministry of Education, Universities and Research, Department of Excellence (MIUR, Italian Law 232/2016).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tamoxifen-resistant breast cancer cells (TamR-BCCs) are characterized by an enhanced metabolic phenotype compared to tamoxifen-sensitive cells. FoxO3a is an important modulator of cell metabolism, and its deregulation has been involved in the acquisition of tamoxifen resistance. Therefore, tetracycline-inducible FoxO3a was overexpressed in TamR-BCCs (TamR/TetOn-AAA), which, together with their control cell line (TamR/TetOn-V), were subjected to seahorse metabolic assays and proteomic analysis. FoxO3a was able to counteract the increased oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) observed in TamR by reducing their energetic activity and glycolytic rate. FoxO3a caused glucose accumulation, very likely by reducing LDH activity and mitigated TamR biosynthetic needs by reducing G6PDH activity and hindering NADPH production via the pentose phosphate pathway (PPP). Proteomic analysis revealed a FoxO3a-dependent marked decrease in the expression of LDH as well as of several enzymes involved in carbohydrate metabolism (e.g., Aldolase A, LDHA and phosphofructokinase) and the analysis of cBioPortal datasets of BC patients evidenced a significant inverse correlation of these proteins and FoxO3a. Interestingly, FoxO3a also increased mitochondrial biogenesis despite reducing mitochondrial functionality by triggering ROS production. Based on these findings, FoxO3a inducing/activating drugs could represent promising tools to be exploited in the management of patients who are refractory to antiestrogen therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsTamoxifenFemaleHumansDrug Resistance, NeoplasmMCF-7 CellsMetabolic ReprogrammingProteomicsForkhead Box Protein O3

Stichwörter der Autor:innen

FoxO3abreast cancercancer metabolismglycolysistamoxifen resistance

Substanzen

TamoxifenFOXO3 protein, humanForkhead Box Protein O3

Autor:innen und Institutionen

  • Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.
  • Translational Medicine, School of Environment and Life Sciences, Biomedical Research Centre (BRC), University of Salford, Greater Manchester M5 4WT, UK.

ORCID-Profile: Marco Fiorillo, Daniela Bonofiglio, Francesca Luisa Conforti, Ines Barone, Catia Morelli, Diego Sisci

Förderung

  • Italian Association for Cancer Research
  • Ministry of Education, Universities and Research
  • Department of Excellence (MIUR, Italian Law 232/2016)
  • Lunella Biotech, Inc.,
  • PRIN 2017
  • AIRC
  • BANDO PRIN 2017
  • Next Generation EU—Italian NRRP

Zitieren

APA

Fiorillo, M., Ricci, E., Fava, M., Longobucco, C., Sotgia, F., Rizza, P., Lanzino, M., Bonofiglio, D., Conforti, F. L., Catalano, S., Barone, I., Morelli, C., Aquila, S., Lisanti, M. P., & Sisci, D. (2023). FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity. Cells. https://doi.org/10.3390/cells12242777

Vancouver

Fiorillo M, Ricci E, Fava M, Longobucco C, Sotgia F, Rizza P, et al. FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity. Cells. 2023. doi:10.3390/cells12242777

BibTeX
@article{Fiorillo2023,
  author = {Fiorillo, Marco and Ricci, Elena and Fava, Mariarosa and Longobucco, Camilla and Sotgia, Federica and Rizza, Pietro and Lanzino, Marilena and Bonofiglio, Daniela and Conforti, Francesca Luisa and Catalano, Stefania and Barone, Ines and Morelli, Catia and Aquila, Saveria and Lisanti, Michael P and Sisci, Diego},
  title = {FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12242777}
}
Kostenlos starten →